ArticleBlood transfusion = Trasfusione del sangue
High prevalence of G6PD mutations in blood donors from the Brazilian Amazon region.
Article in Blood transfusion = Trasfusione del sangue. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of G6PD candidate variants in malaria-endemic populations of northern Brazil.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious DiseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition caused primarily by single nucleotide polymorphisms (SNPs). It is the most prevalent enzymopathy globally and directly impacts the ability of red blood cells to respond to oxidative stress. This study aimed to determine the prevalence of G6PD variants in Amazon blood donors. MATERIALS AND
methodsA cross-sectional study was conducted at the Foundation of Hemotherapy and Hematology of Amazonas (HEMOAM) between January and June of 2024. The study analyzed 5,000 donor samples using the quantitative polymerase chain reaction (qPCR) to detect G6PD genetic variants.
resultsG6PD variants were present in 364 (7.28%) donors, with the most common being c.376A>G (3.82%), c.292G>A (1.92%), and simultaneous c.292G>A/376A>G (0.90%). Other rare variants were also identified, including c.653C>T, c.1093G>A, c.968T>C; c.632A>T; c.1429G>A; c.700G>T; c.1192G>A and c.197T>A/c.202G>A, representing 0.64% of the total. Most donors exhibiting mutations were male (71.7%), with a mean age of 34.1±11.9 years for males and 34.0±10.5 years for females. The most prevalent blood group in both sexes was O+, with a frequency of 59.7% in males and 61.9% in females. DISCUSSION: This study constitutes the most extensive molecular testing for G6PD mutations in the state of Amazonas, offering a comprehensive overview of G6PD deficiency (G6PDd) in the region. The estimated prevalence rate of G6PD mutations among Manaus blood donors was 7.28%, which is consistent with other findings in Brazil. In conclusion, G6PDd has the potential to compromise red blood cell quality during storage and their survival post-transfusion. This study enhanced the methods used to identify mutations impacting blood storage, with the aim of improving transfusion safety and efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.